Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro.

June 21, 2017

prudect name : Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro.
Altiratinib;DCC 2701; DP 5164

Synonyms: CAS NO: 1345847-93-9Molecular Formula: C₂₆H₂₁F₃N₄O₄Molecular Weight: 510.46Purity: 98% minSolubility: In DMSOStorage: -20 oC

843663-66-1 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18498840